In brain, breast, and other common human tumors there is a correlation betw
een expression of the transcriptional activator hypoxia-inducible factor 1
(HIF-1) and tumor grade and vascularization. HIF-1 stimulates angiogenesis
by activating transcription of the gene encoding vascular endothelial growt
h factor (VEGF). HIF-1 is a heterodimer consisting of a constitutively-expr
essed HIF-1 beta subunit and an O-2- and growth factor-regulated HIF-1 alph
a subunit. Recent studies have demonstrated that HIF-1 alpha expression is
increased in tumor relative to normal tissue by two mechanisms. First, decr
eased intratumoral O-2 concentrations provide a physiological stimulus. Sec
ond, genetic alterations that activate oncogene products or inactivate tumo
r suppressor gene products increase HIF-1 alpha expression and/or HIF-1 tra
nscriptional activity independent of the O-2 concentration. Taken together,
these recent data suggest that increased HIF-1 activity provides a molecul
ar basis for VEGF-induced angiogenesis and other adaptations of cancer cell
s to hypoxia that are critical for establishment of a primary tumor and its
progression to the lethal phenotype.